Kristie Kahl

Philadelphia

Vice President of Content at MJH Life Sciences

I'd rather be someone's shot of whiskey than everyone's cup of tea

Featured in: Favicon

mjhlifesciences.com Favicon

healio.com Favicon

newsbreak.com Favicon

ajmc.com

valdostadailytimes.com Favicon

heraldcourier.com Favicon

cancernetwork.com Favicon

onclive.com Favicon

curetoday.com Favicon

dailyamerican.com + 7 more

Articles

Patient-Centered Communication Drives Supportive Care Needs in Incurable Cancer

1 week ago | oncnursingnews.com | Kristie Kahl

The Primary Palliative Care Communication Intervention (PRECURSOR) may improve the psychosocial experiences of patients with incurable gynecologic cancer and their caregivers in the outpatient setting, according to results of a pilot study presented at the 50th Annual ONS Congress. “As cancer treatments have advanced over the last few decades, we have increasing numbers of patients living with incurable cancer as a chronic condition.
Nurse-Led Sessions Enhance Supportive Care for Patients on Clinical Trials

1 week ago | oncnursingnews.com | Kristie Kahl

A nurse-led intervention to address supportive care concerns of patients with cancer taking part in an early phase clinical trial appeared to be useful, effective, and relevant, according to a pilot study presented at the 50th Annual ONS Congress.
Expanding Definition of Cancer Survivorship Highlights Need for New Standards

1 week ago | curetoday.com | Kristie Kahl

A survivorship program at a community health system is utilizing survivorship standards as a roadmap for collaboration across a multidisciplinary approach, as an expert illustrated.
Tailored Intervention Aids Distress, Recovery After Breast-Conserving Surgery

1 week ago | oncnursingnews.com | Kristie Kahl

Psychosocial assessments and tailored interventions to support recovery in the outpatient setting following breast-conserving surgery for patients with early-stage breast cancer is critical to improving patient outcomes, according to Jennifer Ross Majumdar, PhD, CRNA.1A qualitative study of open-ended patient responses, presented at the 50th Annual ONS Congress, underscored the need to address physical and psychological needs in the outpatient setting in order to improve outcomes.
Expanding Definition of Cancer Survivorship Highlights Need for New Standards

1 week ago | oncnursingnews.com | Kristie Kahl

The development of a survivorship program at a community health system has shown promise in utilizing survivorship standards as a road map to collaborate across the multidisciplinary approach, according to Tara Sweeney, BSN, RN, OCN, CHPN.
Intervention Tactics Enhance Outpatient Cancer Care, Reduce ED Visits

1 week ago | oncnursingnews.com | Kristie Kahl

A 10-pronged intervention strategy including education, a nurse-led call center, and same-day infusion appointments, reduced hospital admissions and emergency department (ED) visits by 16% following chemotherapy treatment, according to a presentation from the 50th Annual ONS Congress.
HEART Protocol Leads to Reduction in ED Visits After Chemoradiation

2 weeks ago | oncnursingnews.com | Kristie Kahl

Implementation of a High ED/Admission Risk Therapy (HEART) team protocol led to fewer emergency department (ED) visits, according to a quality improvement project that was presented at the 50th Annual ONS Congress. “This structured approach ensures timely and effective care,” Yun Jeong Seo, DNP, MSN, APRN, FNP-C, a nurse practitioner at Mount Sinai West, said during her presentation.
HER2+ Early Breast Cancer: Tailoring Therapy in the Era of Expanding Options

1 month ago | onclive.com | Kristie Kahl

Although early-stage HER2-positive breast cancer remains a highly heterogeneous disease, its evolving treatment paradigm of tailored approaches has led to a focus on both neoadjuvant and adjuvant strategies based on tumor biology, stage, and patient factors. “We now have an enormous armamentarium of agents for HER2-positive disease: 3 monoclonal antibodies, 3 HER2-targeted TKIs, and 2 antibody-drug conjugates, with many more hot on the trail toward getting approved,” Sara A.
42nd Annual Miami Breast Cancer Conference: The Show and After Show

1 month ago | cancernetwork.com | Kristie Kahl

For over 4 decades, the annual Miami Breast Cancer Conference (MBCC) has served as a premier gathering for multidisciplinary experts committed to improving breast cancer care. Hosted by Physicians’ Education Resource (PER), MBCC 2025 continues its legacy by bringing together medical, surgical, and radiation oncologists, geneticists, pathologists, and radiologists to share cutting-edge advancements and best practices.
Aspirin Is Associated With Reduced Recurrence Risk in PI3K+ CRC

2 months ago | onclive.com | Kristie Kahl

The use of aspirin for 3 years led to a reduction in the risk of recurrence compared with placebo in patients with PIK3CA-mutated colorectal cancer, according to data from the phase 3 ALASCCA trial (NCT02647099) presented at the 2025 Gastrointestinal Cancers Symposium.1 “This is the first trial to show that mutations in this specific signal pathway, also beyond PIK3CA, predict aspirin response, expanding the target population to more than a third of the patients [with non-metastasized...